Suchergebnisse - "Verweyen, Emely L"

PubPharm (6)

1

Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation

enthalten in: Clinical immunology (Orlando, Fla.) | 2024

von Reiter, A. | Verweyen, E. | Queste, E. | +10

2

Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis

enthalten in: The Journal of clinical investigation | 2023

von Verweyen, E. | Thakkar, K. | Dhakal, S. | +7

3

Interfering with interferons : targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)

enthalten in: Rheumatology (Oxford, England) | 2022

von Verweyen, E. | Schulert, G.

ErratumIn: Rheumatology (Oxford). 2023 May 2;62(5):2022. - PMID 36629504

4

Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome : a cohort study

enthalten in: The Lancet. Rheumatology | 2021

von Rodriguez-Smith, J. | Verweyen, E. | Clay, G. | +9

5

Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Verweyen, E. | Pickering, A. | Grom, A. | +1

6

Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis

enthalten in: Arthritis & Rheumatology | 2021

von Verweyen, E. | Pickering, A. | Grom, A. | +1

1
[1]